Does cytomegalovirus status influence acute and chronic rejection in heart transplantation during the ganciclovir prophylaxis era?

This publication has 10 references indexed in Scilit:

• The registry of the international society for heart and lung transplantation: eighteenth official report—2001
  The Journal of Heart and Lung Transplantation, 2001
• Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis
  Circulation, 1999
• Cytomegalovirus Infection–Enhanced Cardiac Allograft Vasculopathy Is Abolished by DHPG Prophylaxis in the Rat
  Circulation, 1997
• Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-alpha promoter.
  American Journal of Respiratory Cell and Molecular Biology, 1997
• HUMAN CYTOMEGALOVIRUS EARLY INFECTION, ACUTE REJECTION, AND MAJOR HISTOCOMPATIBILITY CLASS II EXPRESSION IN TRANSPLANTED LUNG
  Transplantation, 1996
• Cytomegalovirus Antigen Expression, Endothelial Cell Proliferation, and Intimal Thickening in Rat Cardiac Allografts After Cytomegalovirus Infection
  Circulation, 1995
• EXPRESSION OF MHC ANTIGENS IN NORMAL HUMAN LUNGS AND TRANSPLANTED LUNGS WITH OBLITERATIVE BRONCHIOLITIS
  Transplantation, 1989
• Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis
  JAMA, 1989
• Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens
  Nature, 1988
• Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.
  The Journal of Immunology, 1981